Tasmanian Opioid Pharmacotherapy Program Policy and Clinical Practice Standards

TOPP Policy and Clinical Practice Standards Review 2017-2018

The Tasmanian Opioid Pharmacotherapy Program, Policy and Clinical Practice Standards (TOPP) was publicly released on 27 August 2012 by the Minister for Health.

The TOPP provides a contemporary best practice framework for the delivery of opioid pharmacotherapy treatment for opioid dependence in Tasmania.

A review of the TOPP has commenced and details relevant to the review for stakeholders are provided on this page. For any queries, contact the review manager, Jim Galloway, by email adstopp@dhhs.tas.gov.au

Stakeholder documents and activities for the TOPP Review:

  • TOPP Review Terms of Reference
  • Communique - released early December to formally announce the review
  • Call for Submissions - letter to stakeholder organisations; note submissions can be made by individuals or organisations, all feedback is welcome.

    Submissions can be made by mail or email to Jim Galloway

  • Online feedback survey - all stakeholders are encouraged to respond to the relevant survey. The surveys are open from Monday 8 January and the following links will open in survey monkey.
  • Consultation forums - health professional forums are scheduled for late January. Consumer forums are also being coordinated by Advocacy Tasmania.

    Forums for pharmacists, doctors and other health professionals will be held in each region of Tasmania:

  • All sessions are 7:00 to 9:00 pm and light refreshments will be provided. RSVP to Jim Galloway confirming the location of your session to adstopp@dhhs.tas.gov.au

    RegionDetailsRSVP
    South Tuesday, 23 January 2018
    Training Room, Level 2
    Carruthers Building
    St Johns Park, St Johns Avenue, New Town
    RSVP by 16 January
    North West Monday, 29 January 2018
    Beachway Motel
    1-5 Heathcote Street, Ulverstone
    RSVP by 22 January
    North Wednesday, 31 January 2018
    Level 2 Lecture Theatre Foyer,
    Launceston General Hospital
    Charles Street, Launceston
    RSVP by 24 January

The review process is being advised by a Clinical Reference Group which includes consumer and community service organisation representation.

2012 Release of Policy and Clinical Practice Standards

The key principles and clinical practices described in this document are designed to ensure that individuals affected by opioid dependence receive high quality, safe and effective treatment that will provide them with an opportunity to improve the quality of their lives.Download a copy of the August 2012 release of Tasmanian Opioid Pharmacotherapy Program, Policy and Clinical Practice Standards:

Front Cover - Tasmanian Opioid Pharmacotherapy Program, Policy and Clinical Practice Standards